Company Summary - Kiotech International PLC (LSE:KIO)
1.12p
0.00p
Pharmaceuticals & BiotechnologyMarket cap: £2.825m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Development and marketing of biochemical stimulants and those of manufacturers and suppliers of animal feed additives
| Financials - Interim (11/9/2008) | ||
|---|---|---|
| Turnover | £m | 2.69 |
| Pre-tax Profit | £m | 0.21 |
| EPS | p | 0.06 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Richard Rose | Chairman |
| Richard Edwards | Chief Executive |
Products Brands & Subsidiaries
Products & Brands
Ultrabite
Subsidiaries
Ultrabite Ltd; Kiotech Ltd; Agil Ltd
Free Annual Reports
The PrecisionIR Group Annual Reports Service provides you with quick access to annual reports and other information on selected companies.
Broker Sentiment (0 brokers)
No current consensus recommendation available.
| Heading | Date |
|---|---|
| Director/PDMR Shareholding | 23/10/2008 |
| Half-yearly report Interim results | 11/09/2008 |
| Result of AGM | 01/07/2008 |